Trending:
January 12, 2026, 02:58 PM - 7 min read
If nutrient deficiencies develop while someone is eating much less, and that pattern continues for months or years, those deficiencies may persist and lead to problems such as muscle loss, weakened immunity, anaemia, bone loss or impaired neurological function.
Read more
December 23, 2025, 02:31 PM - 2 min read
The US food regulator approved a pill version of the GLP-1 drug, Wegovy, that has been developed by Novo Nordisk, which is also its manufacturer
Read more
November 15, 2024, 09:46 AM - 7 min read
The weight loss drug is extremely effective (people lose about 15% of their body weight in a year). It also appears to have many benefits beyond just weight loss.
Read more
September 27, 2024, 10:26 AM - 5 min read
The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have been shown to lead to significant weight loss in users – as much as 15% or more of their body weight in clinical trials.
Read more
August 7, 2024, 10:58 AM - 2 min read
Originally developed as a treatment for type 2 diabetes, so-called “skinny jabs” containing the appetite-suppressant semaglutide are a relatively recent innovation.
Read more
July 6, 2024, 12:08 PM - 2 min read
Patients using diabetes and weight-loss drugs Ozempic and Wegovy might face a higher risk of developing a serious eye condition. This condition, called a stroke of the optic nerve or NAION, can lead to blindness, as per new research findings.
Read more